Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: Effects associated with Stat3/Survivin

Stem Cells

Volumn 26, Issue 1, 2008, Pages 30-34

  Guo, Ying ^a,b   Mantel, Charlie ^a,b   Hromas, Robert A ^c   Broxmeyer, Hal E ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c Cancer Research and Science Center ^*  (United States)

Author keywords

Apoptosis; Etoposide; Heat stress; Mouse embryonic stem cells; Oct 4; Stat3; Survivin; UV

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAT3 PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; ETOPOSIDE; FLOW CYTOMETRY; HEAT; HOMEODOMAIN PROTEINS; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; ULTRAVIOLET RAYS;

MURINAE;

EID: 38349004471     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0401     Document Type: Article

References (26)

1. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. STEM CELLS 2001;19:193-204.
2. Doetschman TC, Eistetter H, Katz M et al. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985;87:27-45.
3. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 1995;7:862-869.
4. Remenyi A, Pohl E, Scholer HR et al. Crystallization of redox-insensitive Oct1 POU domain with different DNA-response elements. Acta Crystallogr D Biol Crystallogr 2001;57:1634-1638.
5. Remenyi A, Tomilin A, Pohl E et al. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol Cell 2001;8:569-580.
6. Scholer HR, Ruppert S, Suzuki N et al. New type of POU domain in germ line-specific protein Oct-4. Nature 1990;344:435-439.
7. Mantel CR, Guo Y, Lee MR et al. Checkpoint-Apoptosis uncoupling in human and mouse embryonic stem cells: A source of karyotpic instability. Blood 2007;109:4518-4527.
8. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
9. Li F, Altieri DC. The cancer antiapoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 1999;59:3143-3151.
10. Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-368.
11. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
12. Adida C, Crotty PL, McGrath J et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-49.
13. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev 2003;3:46-54.
14. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
15. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-1308.
16. Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999;344:305-311.
17. Uren AG, Coulson EJ, Vaux DL. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem Sci 1998;23:159-162.
18. Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-440.
19. Aoki Y, Feldman GM, Tosato G. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003;101:1535-1542.
20. Gritsko T, Williams A, Turkson J et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006;12:11-19.
21. Kanda N, Seno H, Konda Y et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23:4921-4929.
22. Yasuda SY, Tsuneyoshi N, Sumi T et al. NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells 2006;11:1115-1123.
23. Yates A, Chambers I. The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans 2005;33:1518-1521.
24. Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630-1635.
25. Sasse J, Hemmann U, Schwartz C et al. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol 1997;17:4677-4686.
26. Matoba R, Niwa H, Masui S et al. Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 2006;1:e26.